Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Lane

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
Blood|July 7, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell NeoplasmAndrew A Lane, Marlise R Luskin, Julia H Keating, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Cell Reports|November 15, 2018
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 OverexpressionCody T Mowery, Jaime M Reyes, Lucia Cabal-Hierro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Cell|March 5, 2019
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and ImmunityPeter van Galen, Volker Hovestadt, Marc H Wadsworth Ii, et al.
Science (New York, N.Y.)|April 22, 2017
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitorsAlexandra-Chloé Villani, Rahul Satija, Gary Reynolds, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Leukemia & Lymphoma|March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclaxEvan C Chen, Yiwen Liu, Courtney E Harris, et al.
Blood|July 7, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell NeoplasmAndrew A Lane, Marlise R Luskin, Julia H Keating, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2023
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone MarrowSam Sadigh, Daniel J DeAngelo, Jacqueline S Garcia, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
The Lancet. Oncology|February 29, 2024
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 studyNaval G Daver, Pau Montesinos, Daniel J DeAngelo, et al.
Cell Reports|November 15, 2018
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 OverexpressionCody T Mowery, Jaime M Reyes, Lucia Cabal-Hierro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Cell|March 5, 2019
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and ImmunityPeter van Galen, Volker Hovestadt, Marc H Wadsworth Ii, et al.
Science (New York, N.Y.)|April 22, 2017
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitorsAlexandra-Chloé Villani, Rahul Satija, Gary Reynolds, et al.
Pageof 11